EXAMINING THE DIFFERENCES BETWEEN PATIENTS TREATED FOR MAJOR DEPRESSIVE DISORDER COMPARED TO THOSE WHO DO NOT REALIZE THEY HAVE MAJOR DEPRESSIVE DISORDER
Author(s)
Gross HJ1, Vietri J2, Chapnick J11Kantar Health, Princeton, NJ, USA, 2Kantar Health, New York, NY, USA
Presentation Documents
OBJECTIVES: Major Depressive Disorder (MDD) has a profound negative impact on sufferers’ lives. This analysis sought to identify differences in patient characteristics and outcomes associated with self-report of depression and use of prescription treatment within a positively-screened MDD population. METHODS: Data were taken from the US 2011 National Health and Wellness Survey (n=75,000), a cross-sectional Internet-based survey representative of US adults. Patients with MDD were identified using the Patient Health Questionnaire (PHQ-9). Health-related quality of life (HRQoL) was assessed with the SF-12 Health Survey (SF-12v2), and activity impairment was measured with the Work Productivity and Activity Impairment questionnaire (WPAI). Comparisons between patient groups were made with chi-square tests for categorical variables and ANOVA for continuous variables. RESULTS: PHQ-9 scores identified MDD in 6.3% of respondents (n=4,720); 33.5% (n=1,583) reported depression and prescription treatment, 30.0% (n=1418) reported depression without prescription treatment, and 36.4% (n=1719) did not self-report depression. Compared to those who did not self-report depression, treated patients were more likely to have severe depression according to PHQ-9 scores (32.5% vs. 22.2%), had lower mental HRQoL (28.5 vs. 37.3), and more activity impairment (60.5% vs. 47.4%) (ps<0.001); however, fewer treated patients visited the emergency room in the past 6 months (25.0% vs. 21.3%, p<0.001). Patients who did not report depression were more likely to have completed college (34.6% vs. 30.6%) and had higher incomes (37.6% with incomes over $50,000 vs. 32.4%), but were less likely to have insurance (70.5% vs. 80.6%), and those with insurance were less likely to have prescription drug coverage (60.2% vs. 74.4%) (ps<0.001). CONCLUSIONS: Patients who had MDD according to PHQ-9 but did not report depression had less severe depression and a higher mental QoL than treated patients, but still had poor health outcomes. Less comprehensive insurance coverage may be a barrier in seeking treatment.
Conference/Value in Health Info
2012-06, ISPOR 2012, Washington, D.C., USA
Value in Health, Vol. 15, No. 4 (June 2012)
Code
PMH46
Topic
Patient-Centered Research
Topic Subcategory
Health State Utilities
Disease
Mental Health